MedTrace Logo

Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis

NCT04811911 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-03-23

No results posted yet for this study

Summary

The aim of the study is to evaluate the effect of NB-UVB versus MTX on serum TWEAK level in psoriatic patients.

Conditions

Interventions

RADIATION

Narrowband ultraviolet B

Patients will receive 8 sessions of NB-UVB per month for 3 successive months

DRUG

Methotrexate

Patients will receive 25 mg/1ml of methotrexate vial per week for 3 successive months

Sponsors & Collaborators

  • Aswan University Hospital

    lead OTHER

Principal Investigators

  • Moustafa A El Taieb, Professor · Faculty of medicine aswan university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-13
Primary Completion
2021-09-15
Completion
2021-12-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04811911 on ClinicalTrials.gov